Related references
Note: Only part of the references are listed.EXTRA-ABDOMINAL DESMOID TUMOR: LOCAL RECURRENCE AND TREATMENT OPTIONS
Luiz Eduardo Moreira Teixeira et al.
ACTA ORTOPEDICA BRASILEIRA (2016)
Long-term outcomes of 47 patients with aggressive fibromatosis of the chest treated with surgery
D. Ma et al.
EJSO (2016)
Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study
Danique L. M. van Broekhoven et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution
X. D. He et al.
EJSO (2015)
Benign breast tumors: Recommendations of College National des Gynecologues Obstetriciens Francais (CNGOF) - Short text
V. Lavoue et al.
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION (2015)
Treatment of Aggressive Pelvic Fibromatosis With Interferon
Femke Arien et al.
OBSTETRICS AND GYNECOLOGY (2015)
Postoperative recurrence of desmoid tumors: clinical and pathological perspectives
Yi-fei Wang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Benign breast tumors: Recommendations of College National des Gynecologues Obstetriciens Francais (CNGOF) - Short text
V. Lavoue et al.
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION (2015)
Desmoid-Type Fibromatosis and Pregnancy A Multi-institutional Analysis of Recurrence and Obstetric Risk
Marco Fiore et al.
ANNALS OF SURGERY (2014)
Desmoid tumor-associated pain is dependent on mast cell expression of cyclooxygenase-2
Makoto Emori et al.
DIAGNOSTIC PATHOLOGY (2014)
Extra-abdominal desmoid fibromatosis - A sarcoma unit review of practice, long term recurrence rates and survival
N. Eastley et al.
EJSO (2014)
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis
Jae-Cheol Jo et al.
INVESTIGATIONAL NEW DRUGS (2014)
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998)
R. B. Keus et al.
ANNALS OF ONCOLOGY (2013)
CTNNB1 45F Mutation Is a Molecular Prognosticator of Increased Postoperative Primary Desmoid Tumor Recurrence An Independent, Multicenter Validation Study
Chiara Colombo et al.
CANCER (2013)
Aggressive fibromatosis in the head and neck region: Benign tumor with often mutilating effects
Mathijs P. Hendriks et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
β-Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors
John T. Mullen et al.
ONCOLOGIST (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Imatinib Use in Pregnancy
Michael J. Webb et al.
TURKISH JOURNAL OF HEMATOLOGY (2012)
Recurrence Patterns and Management Options in Aggressive Fibromatosis
Rajaraman Ramamurthy et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2012)
Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
Mrinal M. Gounder et al.
CLINICAL CANCER RESEARCH (2011)
A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses
Marry H. Nieuwenhuis et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Desmoid Tumors: Clinical Features and Treatment Options for Advanced Disease
Bernd Kasper et al.
ONCOLOGIST (2011)
Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors
Keith M. Skubitz et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Treatment of extra-abdominal aggressive fibromatosis with pegylated interferon
Gabriele Stengel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Nonclinical Safety Evaluation of Sunitinib: A Potent Inhibitor of VEGF, PDGF, KIT, FLT3, and RET Receptors
Shem Patyna et al.
TOXICOLOGIC PATHOLOGY (2008)
IFN-β signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors
Sean S. Tjandra et al.
CANCER RESEARCH (2007)
Tarnoxifen therapy for aggressive fibromatosis of the posterior triangle of the neck
Luc G. Morris et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2007)
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibrornatosis
Stefano Signoron et al.
CLINICAL CANCER RESEARCH (2007)
Pregnancy on imatinib: fatal outcome with meningocele
DR Choudhary et al.
ANNALS OF ONCOLOGY (2006)
High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors
A Hansmann et al.
CANCER (2004)
Chest wall desmoid tumors: Results of surgical intervention
AE Abbas et al.
ANNALS OF THORACIC SURGERY (2004)
Interferon-induced remission of rapidly growing aggressive fibromatosis in the temporal fossa
JD Raguse et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)
Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway
SC Abraham et al.
HUMAN PATHOLOGY (2002)
Share Paper
